«

»

FDA declines to give accelerated approval to Lilly’s Alzheimer’s drug, firm says

The Food and Drug Administration said it needed safety data on more patients, the company said.

Read the full post at Health
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive